Invenra Inc., a leader in multispecific antibody discovery and development, today announced the launch of its B-Body Express™ Antibody Expression service. This new offering enables biotechnology and ...

This new offering enables biotechnology and pharmaceutical companies to rapidly access Invenra's premier B-Body® bispecific antibody platform, delivering high-purity, validated bispecific ...

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

Sanofi is continuing to splash the cash for autoimmune and immunology assets this spring by penning a new deal with ...

Swiss oncology firm Veraxa Biotech is set to go public in the US through a merger with Voyager Acquisition Corp, a healthcare ...

AbTherx's antibody discovery platform is powered by Atlas Mice ... which enables native-like IgG bispecific antibodies that improve manufacturability and developability. This is accomplished ...

Earendil Labs and Sanofi today announced that they have entered into a license agreement for two potential first-in-class ...

Market turmoil may have frozen the traditional IPO pipeline, but German antibody biotech Veraxa is turning to the special purpose acquisition company (SPAC) model to hop onto the Nasdaq. | Market ...